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Abstract
Background: The first reports of the Chinese experience in the management of newborns of mothers with SARS-
CoV 2 infection did not recommend mother-baby contact or breastfeeding. At present, the most important
International Societies, such as WHO and UNICEF, promote breastfeeding and mother-baby contact as long as
adequate measures to control COVID-19 infection are followed. In cases where maternal general health conditions
impede direct breastfeeding or in cases of separation between mother and baby, health organizations encourage
and support expressing milk and safely providing it to the infants.
Methods: A series of 22 case studies of newborns to mothers with COVID-19 infection from March 14th to April
14th, 2020 was conducted. Mothers and newborns were followed for a median period of 1.8 consecutive months.
Results: Out of 22 mothers, 20 (90.9%) chose to breastfeed their babies during hospital admission. Timely initiation
and skin to skin contact at delivery room was performed in 54.5 and 59.1%, respectively. Eighty two percent of
newborns to mothers with COVID-19 were fed with breast milk after 1 month, decreasing to 77% at 1.8 months. Six
of 22 (37.5%) mothers with COVID-19 required transitory complementary feeding until exclusive breastfeeding was
achieved. During follow-up period, there were no major complications, and no neonates were infected during
breastfeeding.
Conclusions: Our experience shows that breastfeeding in newborns of mothers with COVID-19 is safe with the
adequate infection control measures to avoid mother-baby contagion. Supplementing feeding with pasteurized
donor human milk or infant formula may be effective, until exclusive breastfeeding is achieved.
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Background
Severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) is an RNA virus that causes coronavirus disease
2019 (COVID-19) [1]. The first COVID-19 case was re-
ported on Dec 31, 2019 [2], and to date more than 11
million people worldwide have been affected by COVID-
19 [3].
The World Health Organization (WHO) declares
breastmilk as the ideal food for infants because is safe,
clean and contains antibodies which help protect against
many common childhood illnesses. Breastmilk provides
all the energy and nutrients that the infant needs for the
first months of life, and it continues to provide up to
half or more of a child’s nutritional needs during the
second half of the first year, and up to one third during
the second year of life.
Since March 18th, 2020, the WHO recommends that
women with COVID-19 can breastfeed if they wish to
do so, based on the idea that through breastmilk the
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babies would get antibodies and anti-infective factors
that help protect newborns from getting infections [4].
The WHO encourages women to breastfeed or to con-
tinue breastfeeding following certain recommendations
and precautions [4].
Currently, it is uncertain whether the virus can be
transmitted through breastmilk; our understanding of
viral transmission is limited and based on a few reports
where they did not find traces of the virus in breastmilk
[5–7].
Also, there is some disagreement in the literature
among breastfeeding management in confirmed
COVID-19 patients, Wang et al., did not recommend
breastfeeding in suspected cases, uncured cases and
while taking lopinavir/ritonavir treatment [7]. In
addition, neonatal isolation was recommended in new-
borns who had been suspected or confirmed SARS-CoV
2 infection [8]. On the other hand, the Union of Euro-
pean Neonatal and Perinatal Societies advise direct
breastfeeding under strict measures of infection control
in asymptomatic COVID-19 mothers, but when the
mothers are too sick, the neonates will be managed sep-
arately with fresh expressed breastmilk [9].
We are presenting a series of representative cases of
infants who received breastfeeding from COVID-19
mothers. We’ve described the management of the
mothers and babies during breastfeeding, the indication
of breastfeeding depending on the severity of symptoms
and finally breastfeeding in preterm neonates during
NICU admission.
Methods
This is a retrospective case series study that recruited 23
consecutive mothers with COVID-19 after delivery from
14 March to 14 April 2020. The study was approved by
the University Hospital Puerta de Hierro Research Ethics
Committee and Informed Consent was obtained from all
patients. One patient revoked her Informed Consent
with 22 patients remaining in the study.
The objective of the study was to describe the types of
lactation of the COVID-19 mothers, to identify if there
were added difficulties and to assess the risk of infection
of the newborns.
Data was obtained from medical records and by phone
survey, including: maternal age, gestational age, timing
of maternal infection (prior or after birth), symptoms or
pneumonia, type of delivery, medications prior and after
birth, neonatal Reverse Transcription Polymerase Chain
Reaction (RT-PCR) testing, timely initiation of breast-
feeding, skin to skin contact, type of feeding, breastfeed-
ing complications, follow-up, infant infection, and
weight gain.
The protocols for COVID-19 treatment at our hospital
were: a) Protocol 1: Mainly symptomatic treatment; b)
Protocol 2: hydroxychloroquine 400mg/12 h × 1 day,
200 mg/12 h × 5 days + azithromycin 500 mg × 5 day; c)
Protocol 3 for pregnant patients: Protocol 1 × 5–14 days
+ darunavir (800 mg) + ritonavir (100 mg) daily; and d)
Protocol 4 in puerperium: Protocol 1 × 5–14 days + lopi-
navir (400 mg) + ritonavir (100 mg) daily.
After delivery, all neonates were tested for SARS-CoV
2 in the first two hours of life by quantitative RT-PCR
on samples from the respiratory tract (nasopharyngeal
swab). During the COVID-19 pandemic, we have pro-
moted the early or timely feeding and skin-to-skin con-
tact in the delivery room. Timely initiation was defined
as the one that occurs spontaneously within the first
hour after birth. Temporary separation of mothers with
COVID-19 was considered when rooming-in did not
occur and/or skin-to- skin contact was avoided.
According to the standard WHO definitions, newborn
feeding were classified as follows: a) Exclusive Breast-
feeding: breastmilk, including milk expressed, donor or
from a wet nurse; b) Complementary Feeding: breast-
milk, including milk expressed, donor or from a wet
nurse and may also receive infant formula; and c) infant
formula. All the indicators described above, measure
feeding in the previous 24 h [10].
All mothers with COVID-19 at hospital discharge re-
ceived Lactancia materna ante la pandemia de Corona-
virus COVID-19 (IHAN) breastfeeding written
recommendations [11]. Follow-up of mothers with
COVID-19 infection and newborns was done by phone
by a pediatrician during a period of 14 days every three
days and then by obstetricians.
Results
Twenty-three consecutive deliveries by mothers with
COVID-19 were attended at our Hospital during the
first thirty days of the pandemic and 22 were included in
this study. The median age of the mothers was 34 years
(range, 19–43) and the median gestational age was 38 +
5 weeks (range, 31 + 6–41 + 3 weeks). All mothers were
COVID-19 infected prior to delivery. Demographics of
the case series study are shown in Table 1.
Out of 22 mothers with COVID-19, 11 (50%) were
symptomatic. Of all patients, four received treatment for
COVID-19 prior to delivery and four in the puerperium.
Twenty-two newborns tested negative for SARS-CoV-2
by RT-PCR nasopharyngeal swabs and two born preterm
needed admission to the NICU. Clinical course of
mothers and newborns are described in Table 1.
Timely initiation and skin to skin contact were per-
formed at delivery room in twelve and thirteen of cases,
respectively. Of twenty-two patients, only two patients
expressed their desire of lactation suppression. Most
newborns (72.7%) were fed with exclusive breast milk,
although six of them (37.5%) required transitory
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complementary feeding until exclusive breastfeeding was
achieved. In addition, complementary feeding with infant
formula was required in cases 13 and 16, one of them
switched to feeding only with infant formula after seven
weeks (case 13).
The median length of follow-up was 53.5 days (range,
30–73 days) and the median weight gain was 1351.5 g
(range, 270–2300 g). Out of 22 newborns, 81.8% were
breastfed at month, and the percentage dropped to
77.3% at censoring date. Throughout follow-up period,
all newborns were free of COVID-19 infection. Results
are shown in Table 2.
Case presentations
In situations of admission to special units or when
mothers presented symptoms, the cases were managed
as follows, in order to achieve exclusive breastfeeding:










































30 PB Pneumonia H + D/C S NEG Symptomatic No No No 2.2
5 37 +
6
39 PB Mild Symptomatic S NEG Symptomatic No No No 1.4
6 38 +
1
37 PB Mild Symptomatic S NEG Symptomatic No No No 2.0
7 38 +
2
31 PB No Symptomatic I NEG Symptomatic No No No 2.1
8 38 +
2
23 PB Pneumonia H S NEG H No No No 1.8
9 38 +
3
35 PB No No I NEG Symptomatic No No No 1.8
10 38 +
3
37 PB No No CS NEG Symptomatic No No No 1.8
11 38 +
6
26 PB Pneumonia H + Az CS NEG H + Az No No No 1.8
12 39 +
1
38 PB Mild Symptomatic S NEG Symptomatic No No No 1.4
13 39 +
2
31 PB No No S NEG Symptomatic No No No 1.8
14 39 +
2
31 PB No No S NEG Symptomatic No No No 1.7
15 39 +
3





39 PB Mild Symptomatic S NEG Symptomatic No No No 1.7
17 39 +
6
31 PB No No I NEG Antibiotic Mastitis No No 1.7
18 40 +
0
34 PB No No S NEG Symptomatic No No No 1.5
19 40 +
3
34 PB No No S NEG Symptomatic No No No 1.5
20 40 +
4
38 PB Mild Symptomatic S NEG Symptomatic No No No 1.8
21 41 +
1
37 PB No No S NEG Symptomatic No No No 1.5
22 41 +
3
29 PB Mild Symptomatic S NEG Symptomatic No No No 1.4
Abbreviations: GA: gestational age; WG: week gestation; yr: years; PB: COVID-19 prior birth; RT-PCR: Reverse Transcription Polymerase Chain Reaction to infant
nasal swab 2 h after birth; AB: after birth; FU: Follow-up; Mth: months; H: Hydroxychloroquine; Az: Azithromycin; L: Lopinavir; D: Darunavir; R: Ritonavir; S:
Spontaneous; CS: Cesarean section; I: instrumental; NEG: negative; NICU: neonatal intensive care unit; ICU: intensive care unit
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NICU or ICU admission
Case 1 and 2: Newborns of two preterm deliveries
needed Neonatal Intensive Care Unit (NICU) admission,
one because of a respiratory distress syndrome and the
other for hemolytic anemia. There were no timely feed-
ing and no skin-to-skin contact at delivery room due to
prematurity and transfer to the neonatology unit. After
24 h, oral feeding was done in case 1, with pasteurized
donor human milk and expressed breast milk until the
17th day and from then with exclusive breast milk. In
case 2, feeding was done with pasteurized donor human
milk until the 18th day, followed by a period of three
weeks of supplementing breastmilk with infant formula
before achieving exclusive breastfeeding.
Case 3: Mother required Intensive Care Unit (ICU) ad-
mission due to HELLP syndrome and her newborn was
transferred to the neonatology unit. Timely feeding and
skin to skin contact was not done. The newborn was fed
by pasteurized donor human milk during the first 14 h
after birth. Subsequently, breastfeeding with expressed
breast milk was done up to the 16th day and from then
exclusively breastfeeding.
Symptomatic mothers: Of 11 symptomatic patients, 5
(22.7%) were due to pneumonia and 6 (27.3%) cases due
to mild symptoms.
Cases 4, 8, and 11 were the remaining mothers with
COVID-19 and pneumonia. Case 4 completed treatment
prior delivery and case 8 and 11 after delivery. Timely
feeding and skin to skin contact was done only in case
11. Case 4 was fed with infant formula until the 4th
week and then restarted exclusive breastfeeding. Case 8
underwent lactation suppression from the beginning. In
case 11, exclusive breastfeeding occurred until the 2nd
week, then infant formula was used since the mother de-
cided to stop breastfeeding.
Cases 5, 6, 12, 16, 20 and 22: Timely feeding and skin
to skin contact were done in 50 and 66.7% of cases, re-
spectively. Due to mother’s symptoms, cases 5, 6 and 20
Table 2 - Breastfeeding follow-up of 22 mothers with COVID-19
Case Skin to skin contact
in 1st hour
Early initiation of





























E E E E E NA NA NA NA 1303
2 No No D D D +
Ex
E + F E + F E + F E E E E E 1945
3 No No D D E E E E NA NA NA NA NA 270
4 No No F F F F E E E E E E NA 2300
5 No No D + F F F F F F F NA NA NA NA 1655
6 No No Ex +
F
E E E E E E E E NA NA 900
7 No No Ex +
F
E E E E E E E E NA NA 2250
8 No No F F F F F F F F NA NA NA 1430
9 Yes Yes E E E E E E E E NA NA NA 1560
10 Yes Yes E E E E E E E E NA NA NA 1100
11 Yes Yes E E F F F F F F NA NA NA 500
12 Yes No F F F F F F NA NA NA NA NA 900
13 Yes Yes S S S S S S S F NA NA NA 1300
14 Yes Yes E E E E E E E E NA NA NA 1200
15 No No E E E E E E E E NA NA NA 2020
16 Yes Yes E S S S S S S S NA NA NA 1700
17 Yes Yes E E E E E E E E NA NA NA 300
18 Yes Yes E E E E E E E NA NA NA NA 1412
19 Yes Yes E E E E E E E NA NA NA NA 1038
20 Yes Yes D +
Ex
E E E E E E E E NA NA 2120
21 Yes Yes E E E E E E E NA NA NA NA 1400
22 Yes Yes E E E E E E E NA NA NA NA 1300
Abbreviations: WG: Weight gain (birth to follow-up); gr: grams; D: Donated Breast Milk; Ex: Express Breast Milk; S: Supplementing with formula; E: Exclusive Breast
Milk; F: Formula; NA: Not available
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required supplements for 48 h (cases 5: pasteurized
donor human milk + infant formula; case 20: pasteurized
donor human milk + expressed breast milk; and case 6:
expressed breast milk +infant formula). Case 5 contin-
ued with infant formula due to lactation suppression
and case 6 and 20 with exclusive breast milk. Case 16,
after one week of exclusive breastfeeding, began supple-
menting with infant formula based on nutritional re-
quirements. Finally, case 12 underwent lactation
suppression due to mother’s desire, while case 22 was
fed with exclusive breastfeeding from the beginning.
Cases 7, 9, 10, 13, 14, 15, 17, 18, 19 and 21 were the
asymptomatic mothers with COVID-19 infection.
Timely feeding and skin to skin contact were done in
90% of them. All cases have been exclusively breastfed
to date, except case 7 who used expressed breast milk
and infant formula during the first 48 h due to mother
and neonate separation, and case 13 that started exclu-
sive breastfeeding for 4 days, continuing with comple-
mentary infant formula feeding until the 7th week and
from the 8th week, the baby was infant formula fed.
Discussion
SARS-CoV-2 virus spreads mainly by droplet transmis-
sion, although it has also been detected in blood and
stool samples [12–14]. So far, the presence of SARS-
CoV 2 in placenta, cord blood, amniotic fluid or breast
milk has not been demonstrated [6–8, 15, 16]. Horizon-
tal contagion between mother and newborn through
droplets is the one we need to be more vigilant.
Experience regarding other respiratory virus pan-
demics are based in a largest series of cases about SARS
infection includes 12 pregnant patients of which only
five infants were born with no evidence of perinatal
transmission [17]. Although no information about
breastfeed is reported [17]. The Society of Obstetricians
and Gynaecologists of Canada recommends SARS in-
fected mothers not to breastfeed until recovered from
infection as well as isolation from the neonate until the
mother is no longer infectious [18]. Pregnant women af-
fected with MERS infection appears to have worse clin-
ical outcomes that patients with SARS. Only 11
pregnancies associated cases have been documented
with 91% having adverse clinical outcomes [19]. There is
no experience reported on breastfeeding and MERS
infection.
The most important societies, such as WHO, UNICEF,
ISUOG, RCOG and ABM promote breastfeeding in this
COVID-19 pandemic but with special precautions. They
also encourage, whenever possible, the skin-to-skin care,
especially after birth in order to facilitate their adapta-
tion to the outside world (stabilizing baby’s temperature,
breathing rate, heart rate, and blood sugar) and the es-
tablishment of breastfeeding [20–24]. The directions of
Italian Society of Neonatology (SIN), Spanish Society of
Neonatology (SeNeo) and Union of European Neonatal
& Perinatal Societies (UENPS) follow these recommen-
dations and they promote the joint management of the
mother and her infant [25]. As well, they warn that it is
important to practice respiratory hygiene, including dur-
ing feeding, such as the use of a medical mask, perform
hand hygiene before and after contact with the infant,
and routinely clean and disinfect surfaces where the
symptomatic mother was in contact with [25, 26].
When maternal general health impedes direct breast-
feeding or in cases of separation of mother and neonate,
mothers should be encouraged and supported to express
milk and safely provide this fresh breastmilk to their in-
fants, while applying appropriate hygiene measures [23].
Additionally, expressed breast milk should not be pas-
teurized because it reduces the biological and immuno-
logical value of human milk [20, 21].
However, the current recommendations in this pan-
demic from de Center for Disease Control and Preven-
tion (CDC), and also from the Chinese Pediatrics
COVID-19 Working Group, should be considered, as
the first choice, to separate temporarily the mother who
has confirmed COVID-19 or is “mother under investiga-
tion”, from the newborn to reduce the risk of transmit-
ting the virus [27]. During this period, they recommend
the expression of milk with adequate hygiene measures,
in order to maintain lactation once they are in direct
contact with their children [27–29]. On the other hand,
the other societies claim that the impact on separation
of mothers and neonates might result in infant formula
feeding [20].
Breastfeeding advice during the COVID-19 outbreak
According with the new evidence, the Breastfeeding
Committee at Puerta de Hierro University Hospital in
Madrid (Spain) approved the breastfeeding in COVID-
19 newly born with the adequate individual protection
measures and with the informed consent of the mother.
Even though there does not seem to be vertical trans-
mission between mother and child, after birth the new-
born is susceptible to person-to-person spread by being
in contact with his mother. For this reason at the begin-
ning of the pandemic no contact between the newborn
and the mother was allowed and breastfeeding was not
recommended [30], but soon after international recom-
mendations were established suggesting that the benefits
of breastfeeding and the mother and child connection
outweighed the risk of transmission [20, 24, 31].
From the emotional wellbeing perspective, avoiding
mother-baby separation following delivery also enhances
mother-baby bonding process. Breastfeeding and early
mother-baby contact may facilitate mother-baby bond
[32]. Breastfeeding also decreases the risk of developing
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postpartum depression [33]. Whenever possible, breast-
feeding should be encouraged at any time. For mothers
and babies who were separated due to their medical con-
dition, breastfeeding may help in the bonding process as
it can protect against mental health problems. In our
case series study of mothers with COVID-19, close to
65% of them performed skin to skin contact with their
newborns and close to 55% of them achieved spontan-
eously breastfeeding during the first hour.
There are a number of precautions during breastfeed-
ing that should be followed to minimize the risk of
transmission [34]: practicing respiratory hygiene (wear-
ing a face mask or suitable alternative), washing hands
thoroughly before and after contact with the baby, rou-
tinely cleaning and disinfecting any surfaces touched,
cleaning thoroughly any infant feeding equipment (in-
cluding breast pumps, bottles and teats) before and after
use and avoid falling asleep with the baby. In our study
we have not diagnosed any infections in newborns.
In this scenario, we identified three turning points
which may be left unanswered in the discussion and
based on our recent experience, we believe that the best
approach to solve these problems are:
a) The first issue is that breastfeeding in COVID-19 pa-
tients under pharmacological treatment is only acceptable
if the parents are informed about the possible risks. The
most extended treatments used to treat the COVID-19 in-
fection such as azithromycin, hydroxychloroquine sulfate,
lopinavir-ritonavir, tocilizumab and methylpredinosolone,
are excreted in very small amounts in breast milk [35–41].
Although no specific studies have been conducted, it
seems that most common medicines used for SARS-CoV-
2 infection are safe and compatible with breastfeeding, so
there are no contraindications or special recommenda-
tions to follow regarding the pharmacological treatment
that breastfeeding mothers receive. The parents should be
informed about this expected minimal exposure of their
newborns to the medications.
Our data suggest the compatibility between breast-
feeding and treatment for mothers with COVID-19.
Most of them (80%), chose to breastfeed their babies.
Additionally, for mothers who are temporarily sepa-
rated from their babies, a transitory supplementation
feeding (with pasteurized donor human milk or infant
formula) could be a solution until exclusive breast-
feeding can be establish.
b) A second problem is that breastfeeding in COVID-
19 patients with severe symptoms or with high viral load
could increase viral transmission. When mothers and
neonates are separated the recommendations are to ex-
press milk to provide it to their infants, but when the
mothers are unwell, with fever, in need of oxygen ther-
apy and are even admitted to the intensive care unit, ex-
pressing milk might be a real challenge for them.
We think that to achieve this, mothers must have an
important external help and guidance: specialists who
help them with extraction techniques and emotionally
support them. They should also be offered support to be
able to make the decision to stop breastfeeding if it be-
comes a burden. These women should explore the possi-
bility of re-lactation (restarting breastfeeding after a
gap), wet nursing (another woman breastfeeding or car-
ing for your child) or using donor human milk. Which
approach to use will depend on cultural context, accept-
ability, and the availability of support services. In our
study, out of 11 symptomatic patients, nine mothers re-
quired temporary separation mother-baby. In these
cases, newborns were transfer to the neonatology unit.
During this period, 50% of mothers with mild symptoms
required supplementing their newborns for 48 h. At the
end of the follow-up period, close to 65% of symptom-
atic mothers with COVID-19 breastfeed their babies: 6
exclusive breastfeeding and 1 supplementing with infant
formula.
c) The third issue is how to manage breastfeeding
while the newborn is admitted inside the NICU. In these
cases, two special challenges are going to be presented
to the COVID-19 mothers; the first that they must be
isolated and will not be allowed to visit the neonatal
units due to the risk of contagion (NICU or ICU admis-
sion rate was between 16 to 18 days). And the second,
that even if they express their milk and follow the rec-
ommendations of the WHO and IHAN, the profes-
sionals responsible for their newborns may not accept it
because of the risk that the milk or its containers are
contaminated. Again, in this situation, emotional sup-
port for these mothers must be always offered. In our
experience, achieving exclusive breastfeeding is possible
even though the infants were admitted or isolated for
prolonged periods; the infants of cases 1, 2 and 3 ended
up with exclusive breastfeeding after a feed gap were a
combination of pasteurized donor human milk and
mother’s expressed breast milk was given to them.
In summary, despite all difficulties, 82% of newborns
to mothers with COVID-19 were breastfed for the first
month, decreasing to 77% at 1.8 months, being 73% of
them exclusive breastfeeding, although more than a third
of them required complementary breastfeeding tempor-
arily. This event occurred with minimal maternal and
newborn complications, and no neonates were infected
during breastfeeding.
Conclusions
Despite the COVID-19 pandemic, the international or-
ganizations continue to promote breastfeeding. Our ex-
perience shows that breastfeeding is safe with correct
infection and control measures to decrease the risk of
contagion by droplets and by contact with the
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respiratory secretions between mother and infant. When
mother-baby child separation occurs, supplementing
feeding with pasteurized donor human milk or infant
formula may be effective until breastfeeding is resumed.
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